Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc. is a privately held dermatology therapeutics company headquartered in West Chester, Pennsylvania. Founded in 2013, Verrica employs 106 people and has generated $50 million in annual revenue. Verrica Pharmaceuticals develops medications for various skin diseases that require medical intervention. Their focus is on creating safer and more effective treatments to alleviate patient suffering while streamlining the treatment process for both physicians and patients. The company aims to improve access to therapies and provide peace of mind to patients, parents, and caregivers. Verrica Pharmaceuticals distinguishes itself through its commitment to developing innovative dermatology treatments. The company's management team boasts extensive experience in the pharmaceutical industry, having collectively launched over 50 products. Their expertise spans drug development through commercialization, ensuring a comprehensive approach to bringing new therapies to market. For more information about Verrica Pharmaceuticals and their groundbreaking dermatology treatments, please visit verrica.com.

Verrica Pharmaceuticals is a dermatology therapeutics company specializing in the development of medications for skin diseases. The company is located at 44 West Gay Street, Suite 400, West Chester, PA 19380. Verrica Pharmaceuticals is committed to innovation in the field of dermatology and aims to provide significant benefits for individuals affected by skin diseases. Verrica Pharmaceuticals operates within the healthcare, pharmaceuticals, and biotechnology industries. Their focus is on developing therapeutic solutions for dermatological conditions. The company's commitment extends to patient care and the provision of effective treatment options. Verrica Pharmaceuticals' competitive advantages include innovation in dermatology therapeutics and a commitment to patient care and treatment solutions. The company's values and culture are centered around innovation, a patient-first approach, collaboration and teamwork, and a performance-oriented culture. Key contacts at Verrica Pharmaceuticals include John Kirby, who serves as the Interim Chief Financial Officer. Chris Calabrese from LifeSci Advisors also works with the company. The company can be contacted via email at [email protected], [email protected], [email protected], and [email protected]. While no phone number is listed, the company's website, verrica.com, provides additional information. Verrica Pharmaceuticals' mission is to develop medications for skin diseases, emphasizing innovation and providing benefits for those living with these conditions. Their approach is patient-focused, collaborative, and performance-driven, reflecting their commitment to advancing dermatology therapeutics.